TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
HALO

Halozyme Therapeutics Inc

Healthcare · Biotechnology

130.90$ -0.2% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Halozyme Therapeutics Inc (HALO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.8% of the shares are freely tradable; institutional investors hold 107.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 107.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 98.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 17.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 114Mio.

Largest Shareholders

Institutions

Institutions HALO
Name Stake (%) Shares Change (%) Date
BlackRock Inc 11.69 13,271,095 +0.0 06/30/2026
Vanguard Capital Management, LLC 4.71 5,351,312 +1.5 06/30/2026
Vanguard Portfolio Management, LLC 4.67 5,299,008 +0.9 06/30/2026
State Street Corp 4.56 5,179,434 +4.9 06/30/2026
Amvescap Plc. 2.80 3,177,997 -20.8 06/30/2026
Morgan Stanley - Brokerage Accounts 2.50 2,832,594 +10.5 06/30/2026
Boston Partners Global Investors, Inc 2.44 2,773,568 +3.3 06/30/2026
Bank of America Corp 2.41 2,740,561 -5.9 06/30/2026

Funds

Funds HALO
Name Stake (%) Shares Change (%) Date
iShares Core S&P Mid-Cap ETF 3.56 4,042,836 +0.0 09/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.18 3,603,899 -4.4 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings HALO
Person Role Shares Value As of Type
Torley Helen PRESIDENT AND CEO 767,780 100,502,402 $ Oct 8, 2026 direct
Posard Matthew L. Director 53,609 7,017,418 $ Oct 1, 2026 direct
Connaughton Bernadette Director 40,418 5,290,716 $ Aug 10, 2026 direct
Daly James M Director 1,169 153,022 $ Oct 1, 2026 direct
Appelhans Dannielle Director 1,161 151,975 $ Sep 1, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Oct 8, 2026 Torley Helen PRESIDENT AND CEO Sell 200 110.51 22,102
Oct 8, 2026 Torley Helen PRESIDENT AND CEO Sell 11,900 110.00 1,308,941
Oct 8, 2026 Torley Helen PRESIDENT AND CEO Sell 3,090 108.91 336,526
Oct 8, 2026 Torley Helen PRESIDENT AND CEO Sell 4,810 108.18 520,341
Oct 8, 2026 Torley Helen PRESIDENT AND CEO Other 20,000 18.41 368,200
Oct 7, 2026 Torley Helen PRESIDENT AND CEO Sell 200 113.69 22,739
Oct 7, 2026 Torley Helen PRESIDENT AND CEO Sell 900 112.78 101,502
Oct 7, 2026 Torley Helen PRESIDENT AND CEO Sell 10,300 111.84 1,151,942
Oct 7, 2026 Torley Helen PRESIDENT AND CEO Sell 8,600 111.03 954,867
Oct 7, 2026 Torley Helen PRESIDENT AND CEO Other 20,000 18.41 368,200
Oct 6, 2026 Torley Helen PRESIDENT AND CEO Sell 1,780 110.81 197,245
Oct 6, 2026 Torley Helen PRESIDENT AND CEO Sell 9,920 109.89 1,090,119
Oct 6, 2026 Torley Helen PRESIDENT AND CEO Sell 6,000 109.33 656,004
Oct 6, 2026 Torley Helen PRESIDENT AND CEO Sell 2,300 107.90 248,175
Oct 6, 2026 Torley Helen PRESIDENT AND CEO Other 20,000 18.41 368,200
Oct 1, 2026 Daly James M Director Other 1,169 0.00 –
Oct 1, 2026 Posard Matthew L. Director Sell 100 110.04 11,004
Oct 1, 2026 Posard Matthew L. Director Sell 1,100 109.57 120,526
Oct 1, 2026 Posard Matthew L. Director Sell 3,300 108.45 357,898
Oct 1, 2026 Posard Matthew L. Director Sell 730 107.17 78,233
Sep 16, 2026 Posard Matthew L. Director Sell 4,000 108.99 435,964
Sep 16, 2026 Posard Matthew L. Director Sell 8,896 108.04 961,124
Sep 16, 2026 Posard Matthew L. Director Sell 3,000 106.83 320,484
Sep 16, 2026 Posard Matthew L. Director Sell 3,100 106.13 329,009
Sep 11, 2026 Torley Helen PRESIDENT AND CEO Sell 4,508 107.55 484,826
Sep 11, 2026 Torley Helen PRESIDENT AND CEO Sell 15,492 107.15 1,660,030
Sep 11, 2026 Torley Helen PRESIDENT AND CEO Other 20,000 18.41 368,200
Sep 10, 2026 Torley Helen PRESIDENT AND CEO Sell 5,412 107.58 582,228
Sep 10, 2026 Torley Helen PRESIDENT AND CEO Sell 14,588 107.01 1,561,091
Sep 10, 2026 Torley Helen PRESIDENT AND CEO Other 20,000 18.41 368,200
Sep 9, 2026 Torley Helen PRESIDENT AND CEO Sell 100 108.67 10,867
Sep 9, 2026 Torley Helen PRESIDENT AND CEO Sell 6,596 107.82 711,187
Sep 9, 2026 Torley Helen PRESIDENT AND CEO Sell 13,304 107.22 1,426,481
Sep 9, 2026 Torley Helen PRESIDENT AND CEO Other 20,000 18.41 368,200
Sep 1, 2026 Appelhans Dannielle Director Other 1,161 0.00 –
Aug 19, 2026 Torley Helen PRESIDENT AND CEO Sell 3,200 107.77 344,848
Aug 19, 2026 Torley Helen PRESIDENT AND CEO Sell 9,600 107.22 1,029,350
Aug 19, 2026 Torley Helen PRESIDENT AND CEO Sell 7,200 106.36 765,778
Aug 19, 2026 Torley Helen PRESIDENT AND CEO Other 20,000 18.41 368,200
Aug 18, 2026 Torley Helen PRESIDENT AND CEO Sell 9,400 104.87 985,816
Aug 18, 2026 Torley Helen PRESIDENT AND CEO Sell 4,897 104.11 509,827
Aug 18, 2026 Torley Helen PRESIDENT AND CEO Sell 5,703 103.08 587,882
Aug 18, 2026 Torley Helen PRESIDENT AND CEO Other 20,000 18.41 368,200
Aug 17, 2026 Torley Helen PRESIDENT AND CEO Sell 7,500 103.48 776,115
Aug 17, 2026 Torley Helen PRESIDENT AND CEO Sell 9,000 102.55 922,977
Aug 17, 2026 Torley Helen PRESIDENT AND CEO Sell 2,100 101.77 213,709
Aug 17, 2026 Torley Helen PRESIDENT AND CEO Sell 500 100.46 50,229
Aug 17, 2026 Torley Helen PRESIDENT AND CEO Sell 900 98.96 89,062
Aug 17, 2026 Torley Helen PRESIDENT AND CEO Other 20,000 18.41 368,200
Aug 10, 2026 Connaughton Bernadette Director Sell 1,626 102.80 167,153

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?